| Position | Action |
|---|---|
| Default position sizing | Size to absorb 5% adverse move given ATR of 3.39 |
| Measured add at $113.44 support zone on bullish reversal | 50-75% sizing |
| Covered-call overlay | $125 strike to raise effective yield toward 4.5% and cap upside at breakout level |
COP's HOLD rating contradicts a stacked bullish moving average alignment, record Q2 earnings of $3.9 billion, doubled buybacks, and a 6.5% direct shareholder yield creating an asymmetric accumulate-on-weakness opportunity with a $133.88 price target.
| Indicator | Value | Signal |
|---|---|---|
| Close | $117.61 | neutral |
| 10 EMA | 117.22 | bullish |
| 50 SMA | 113.44 | bullish |
| 200 SMA | 107.58 | bullish |
| RSI(14) | 54.62 | neutral |
| MACD Line | 1.46 | bullish |
| MACD Signal Line | 1.55 | bullish |
| MACD Histogram | -0.10 | bearish |
| Bollinger Middle Band (20 SMA) | 116.50 | neutral |
| Bollinger Upper Band | 122.22 | bearish |
| Bollinger Lower Band | 110.78 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Own it, don't chase it — deploy measured support add, trim-not-exit trigger, and covered-call overlay to convert Hold thesis into realized alpha
Hold COP at $117.61. The franchise quality (0.66× Net Debt/EBITDA, 6.5% direct shareholder yield, $3.9B Q2 revenue, FCF inflection by 2029, 12.9× forward P/E with 0.93 PEG) supports ownership, but entry sits between $113.44 50 SMA support and $122.22 resistance with deteriorating momentum. Deploy Neutral Analyst's three enhancements: measured add at $113.44 (addresses MSFT Hold lesson), trim-not-exit at 50 SMA break by >1 ATR (addresses CRM lesson), and $125 covered-call overlay (converts directional bet into yield strategy appropriate for wedge pattern). Do not add into Aug 7–Sept 1 binary window or late-October Q3 print where Iran-war-peak comp risk is highest.
When: Bullish reversal at $113.44 support zone
Then: ADD at 50-75% sizing
↩ rebuts: “Bear's 'already priced' argument”
· concedes: Geopolitical de-escalation could compress oil/geopolitical premium; 50 SMA is currently declining; MACD histogram briefly negative at -0.10; Polymarket odds of WTI $110 dropped to 5%
The bull case is a narrative trap built on cherry-picked signals while ignoring deteriorating momentum (MACD -0.10, 50 SMA declining), brutal Q3 comps against peak Iran-war quarters, geopolitical premium draining as de-escalation progresses, and 400bps margin compression masked by commodity tailwinds. COP at $117.61 has no support between here and $135.87, with risk/reward roughly 2:1 to the downside versus 1:1 to the upside.
→ vs conservative: Upside/downside ratio is 3:1 or 4:1, not 1:1, because targets are $133.88–$135.87, not $122; the conservative analyst is confusing 'no breakout yet' with 'no upside available'
→ vs conservative: MACD histogram negative reading is consolidation within uptrend, not reversal signal; the July 7th bullish cross remains intact
→ vs conservative: 50 SMA declining into price is convergence and constructive, not bearish deterioration; 200 SMA is rising steadily confirming uptrend
→ vs conservative: Three failed breakouts at $120 signal coiled spring accumulation, not exhaustion; those who sold after three rejections missed August 2024 entirely
→ vs conservative: CEO transition to 28-year insider CFO Andy O'Brien is a continuity event, not first-time-CEO execution risk; capital discipline will increase, not decrease
→ vs conservative: Q3 2026 comp pressure is already priced into current stock (117.61 vs 135.87 high); framing it as a risk factor is short-termism that causes underweighting at worst time
→ vs conservative: HOLD framework after breakout means chasing entry 3-5 points higher; the trader's plan has it backwards—deploy capital when trigger fires, not after easy money is made
→ vs neutral: Momentum concerns are missing the bigger picture: MACD reset is healthy consolidation, and convergence setup is prelude to next directional move, not stagnation
→ vs conservative: Macro opportunity is being completely ignored; 8% recession odds and 86% no Fed cuts in a Russell 2000 new high environment is goldilocks for energy beta
→ vs conservative: Being underinvested in this setup is itself a risk; refusing to add into a 6.5% direct yield with clearly defined risk boundary is leaving money on the table
| bullish |
| ATR(14) | 3.39 | neutral |
Support: 113.44 · 110.78 · 107.58 | Resistance: 120.48 · 122.22 · 133.88
COP exhibits a constructive recovery structure with bullish stacked moving averages (price above 10 EMA, 50 SMA, and 200 SMA). RSI has recovered from oversold territory (30.02 on 2026-07-01) to neutral 54.62, leaving upside room. MACD remains above zero but the histogram has turned slightly negative (-0.10), indicating fading momentum and consolidation risk. Bollinger Band width of 11.44 suggests moderate volatility. Key resistance at $122.22 (Bollinger upper band) and support at $113.44 (50 SMA). Risk/reward favors HOLD for existing longs with a cautiously bullish bias; new entrants should await breakout confirmation above $122.22 or a pullback to $113.44.
Market Cap
$141.29B
Diluted Shares Outstanding
~1.225B
Stock Price (current)
~$117.6
52-Week High
$135.87
52-Week Low
$85.57
50-Day Moving Average
$113.55
200-Day Moving Average
$107.89
P/E (TTM)
15.58
Forward P/E
12.94
PEG Ratio
0.93
P/B
2.22
Dividend Yield
2.88%
Beta
~1.2
Revenue Q1 26
$15,761M
Revenue Q4 25
$13,392M
Revenue Q3 25
$15,031M
Revenue Q2 25
$14,004M
Revenue Q1 25
$16,517M
Gross Profit Q1 26
$4,296M
Gross Profit Q4 25
$2,577M
Gross Profit Q3 25
$3,625M
Gross Profit Q2 25
$3,509M
Gross Profit Q1 25
$5,077M
EBITDA Q1 26
$6,564M
EBITDA Q4 25
$5,666M
EBITDA Q3 25
$6,126M
EBITDA Q2 25
$6,267M
EBITDA Q1 25
$7,511M
Operating Income Q1 26
$3,387M
Operating Income Q4 25
$1,760M
Operating Income Q3 25
$2,758M
Operating Income Q2 25
$2,606M
Operating Income Q1 25
$4,218M
Net Income Q1 26
$2,183M
Net Income Q4 25
$1,442M
Net Income Q3 25
$1,726M
Net Income Q2 25
$1,971M
Net Income Q1 25
$2,849M
Diluted EPS Q1 26
$1.78
Diluted EPS Q4 25
$1.17
Diluted EPS Q3 25
$1.38
Diluted EPS Q2 25
$1.56
Diluted EPS Q1 25
$2.23
Operating Margin Q1 26
21.5%
Operating Margin Q4 25
13.1%
Operating Margin Q3 25
18.4%
Operating Margin Q2 25
18.6%
Operating Margin Q1 25
25.5%
Revenue FY 2025
$58,944M
Revenue FY 2024
$54,745M
Revenue FY 2023
$56,141M
Revenue FY 2022
$78,494M
EBITDA FY 2025
$25,570M
EBITDA FY 2024
$24,425M
EBITDA FY 2023
$25,783M
EBITDA FY 2022
$37,127M
Operating Income FY 2025
$11,342M
Operating Income FY 2024
$12,783M
Operating Income FY 2023
$15,026M
Operating Income FY 2022
$25,462M
Net Income FY 2025
$7,988M
Net Income FY 2024
$9,245M
Net Income FY 2023
$10,957M
Net Income FY 2022
$18,680M
Diluted EPS FY 2025
$6.35
Diluted EPS FY 2024
$7.81
Diluted EPS FY 2023
$9.06
Diluted EPS FY 2022
$14.57
Net Interest Expense FY 2025
$922M
Net Interest Expense FY 2024
$706M
Net Interest Expense FY 2023
$651M
Net Interest Expense FY 2022
$860M
Effective Tax Rate FY 2025
36.9%
Effective Tax Rate FY 2024
32.4%
Effective Tax Rate FY 2023
32.7%
Effective Tax Rate FY 2022
33.8%
Total Assets Q1 26
$122,725M
Total Assets Q4 25
$121,939M
Total Assets Q3 25
$122,472M
Total Assets Q2 25
$122,599M
Total Assets Q1 25
$124,254M
Stockholders' Equity Q1 26
$64,541M
Stockholders' Equity Q4 25
$64,487M
Stockholders' Equity Q3 25
$64,923M
Stockholders' Equity Q2 25
$65,572M
Stockholders' Equity Q1 25
$65,238M
Total Debt Q1 26
$23,327M
Total Debt Q4 25
$23,444M
Total Debt Q3 25
$23,482M
Total Debt Q2 25
$23,529M
Total Debt Q1 25
$23,784M
Net Debt Q1 26
$17,450M
Net Debt Q4 25
$16,146M
Net Debt Q3 25
$18,222M
Net Debt Q2 25
$18,628M
Net Debt Q1 25
$17,475M
Working Capital Q1 26
$3,643M
Working Capital Q4 25
$3,560M
Working Capital Q3 25
$3,875M
Working Capital Q2 25
$2,953M
Working Capital Q1 25
$3,577M
Current Ratio Q1 26
1.54
Net PP&E (net)
$93.1B
Gross PP&E
$187B
Debt/Equity (book)
0.36×
Net Debt/EBITDA
0.66×
Operating Cash Flow Q1 26
$4,295M
Operating Cash Flow Q4 25
$4,318M
Operating Cash Flow Q3 25
$5,878M
Operating Cash Flow Q2 25
$3,485M
Operating Cash Flow Q1 25
$6,115M
Operating Cash Flow FY 2025
$19,796M
Operating Cash Flow FY 2024
$20,124M
CapEx Q1 26
($2,948M)
CapEx Q4 25
($3,023M)
CapEx Q3 25
($2,866M)
CapEx Q2 25
($3,286M)
CapEx Q1 25
($3,378M)
CapEx FY 2025
($12,553M)
CapEx FY 2024
($12,118M)
CapEx FY 2022
$10.2B
Free Cash Flow Q1 26
$1,347M
Free Cash Flow Q4 25
$1,295M
Free Cash Flow Q3 25
$3,012M
Free Cash Flow Q2 25
$199M
Free Cash Flow Q1 25
$2,737M
Free Cash Flow FY 2025
$7,243M
Free Cash Flow FY 2024
$8,006M
Free Cash Flow (TTM)
$7.41B
Free Cash Flow Yield
~5.2%
Dividends Paid Q1 26
($1,032M)
Dividends Paid Q4 25
($1,038M)
Dividends Paid Q3 25
($975M)
Dividends Paid Q2 25
($984M)
Dividends Paid Q1 25
($998M)
Dividends Paid FY 2025
($3,995M)
Dividends Paid FY 2024
($3,646M)
Dividends Paid FY 2023
$5.58B
Dividends Paid FY 2022
$5.73B
Buybacks Q1 26
($1,041M)
Buybacks Q4 25
($1,057M)
Buybacks Q3 25
($1,284M)
Buybacks Q2 25
($1,225M)
Buybacks Q1 25
($1,552M)
Buybacks FY 2025
($5,118M)
Buybacks FY 2024
($5,541M)
Buybacks FY 2023
$5.45B
Buybacks FY 2022
$9.27B
Total Capital Return FY 2025
$9.1B
Total Capital Return FY 2024
$9.2B
Total Capital Return FY 2023
$11.0B
Total Capital Return FY 2022
$15.0B
Debt Reduction FY 2025
$0.91B
Debt Reduction FY 2024
($4.98B net issuance)
Debt Reduction FY 2023
($2.41B net issuance)
Debt Reduction FY 2022
$3.37B net reduction
Gross Margin (TTM)
~47.2%
Operating Margin (TTM)
32.0%
Net Profit Margin (TTM)
14.5%
EBITDA Margin (TTM)
~41.1%
ROE (TTM)
14.18%
ROA (TTM)
7.31%
Quarterly Dividend
$0.84
Dividend Payout Ratio
~50%
Consecutive Dividend Years
over 90
Share Count Shrink Rate
~4% annually
Diluted EPS (TTM)
$7.55
Forward EPS
$9.09
Book Value Per Share
$52.98
Marathon Oil Synergy Target
$500M+ run-rate
Strengths
Concerns
ConocoPhillips is a high-quality, financially disciplined mega-cap E&P with investment-grade balance sheet (Net Debt/EBITDA 0.66×), attractive valuation (TTM P/E 15.58, Forward P/E 12.94), and compelling shareholder returns (~6.5% direct yield from 2.88% dividend + aggressive buybacks). The company shows early-cycle earnings recovery with Q1 26 EPS of $1.78 up 52% sequentially from Q4 25 trough, while demonstrating strong cash generation (OCF ~$20B annually, FCF $7.2B FY25) and disciplined capital allocation returning $9.1B to shareholders in FY25, representing ~46% of operating cash flow.